Third Phase Of Remdesivir Trials Underway In San Antonio


The third phase of clinical trials involving the drug remdesivir is underway at University Hospital and UT Health San Antonio. The National Institutes of Health is sponsoring the Adaptive COVID-19 Treatment Trial 3. In this trial, remdesivir will be paired with interferon beta-1A, which has the approval of the U.S. Food and Drug Administration for treating multiple sclerosis patients.


Sponsored Content

Sponsored Content